Cargando...
A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder
BACKGROUND: Since about one-third of patients with major depressive disorder (MDD) do not respond adequately to available antidepressants, there is a need for treatments based on novel mechanisms of action. Neuropeptide Y (NPY), a normal brain constituent, is reduced in cerebrospinal fluid of patien...
Guardado en:
| Publicado en: | Int J Neuropsychopharmacol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7770516/ https://ncbi.nlm.nih.gov/pubmed/33009815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyaa054 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|